BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15708181)

  • 1. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
    de Jonge N; Lahpor JR; van Wichen DF; Kirkels H; Gmelig-Meyling FH; van den Tweel JG; Doevendans PA; de Weger RA
    Int J Cardiol; 2005 Feb; 98(3):465-70. PubMed ID: 15708181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative transesophageal echocardiography is beneficial for hemodynamic stabilization during left ventricular assist device implantation in children.
    Scohy TV; Gommers D; Maat AP; Dejong PL; Bogers AJ; Hofland J
    Paediatr Anaesth; 2009 Apr; 19(4):390-5. PubMed ID: 19183405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of left ventricular support on right ventricular mechanics during experimental right ventricular ischemia.
    Moon MR; Castro LJ; DeAnda A; Daughters GT; Ingels NB; Miller DC
    Circulation; 1994 Nov; 90(5 Pt 2):II92-101. PubMed ID: 7955292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
    Madigan JD; Barbone A; Choudhri AF; Morales DL; Cai B; Oz MC; Burkhoff D
    J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected].
    Maeder MT; Leet A; Ross A; Esmore D; Kaye DM
    J Heart Lung Transplant; 2009 Apr; 28(4):360-6. PubMed ID: 19332263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of right ventricular dysfunction after left ventricular assist device implantation.
    Nakatani S; Thomas JD; Savage RM; Vargo RL; Smedira NG; McCarthy PM
    Circulation; 1996 Nov; 94(9 Suppl):II216-21. PubMed ID: 8901749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of timing right ventricular assist device withdrawal using left ventricular assist device filling characteristics.
    Mandarino WA; Winowich S; Gasior TA; Pham S; Griffith BP; Kormos RL
    ASAIO J; 1997; 43(5):M801-5. PubMed ID: 9360157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
    Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
    Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.